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Purpose: To identify differentially expressed genes in keratoconus (KC) corneal fibroblasts.
Methods: Stromal keratocytes (having a fibroblast morphology) from KC keratoplasty specimens and eye bank donor
corneas were isolated and expanded using a serum containing medium. RNA was isolated from three KC fibroblast cultures
and five eye bank donor cornea fibroblast cultures. The targets from the cultured fibroblasts were hybridized to the
Affymetrix U133 Plus 2.0 microarrays. Western blot analyses of cell lysates were performed to examine protein levels of
interest  in  the  two  groups.  Protein  levels  of  select  differentially  expressed  genes  were  further  examined  by
immunohistochemistry. Keratocyte staining of archived KC keratoplasty specimens were graded using a 0 to 3+ scale and
compared to five archived whole globes having normal corneas as well as to 10 Fuchs’ dystrophy keratoplasty specimens.
Results: Microarray analysis revealed up to a 212 fold reduction in the mRNA levels of alcohol dehydrogenase (class 1)
beta polypeptide (ADH1B) in KC fibroblasts (p=0.04). Decreased alcohol dehydrogenase in KC fibroblasts was confirmed
by western blot analysis of early passage primary keratocyte cell lysates. Immunohistochemistry using a monoclonal
mouse immunoglobulin G (IgG) against human liver alcohol dehydrogenase revealed a dramatic difference in protein
staining in the keratocytes of the KC group compared to the normal cornea group. Immunohistochemistry also showed
decreased immunostaining against alcohol dehydrogenase in the KC stromal sections compared to those obtained from
Fuchs’ endothelial corneal dystrophy samples.
Conclusions: Decreased alcohol dehydrogenase in KC corneal fibroblasts represents a strong marker and possible
mediator of keratoconus.
Keratoconus (KC) is a non-inflammatory ectasia of the
cornea that results in marked stromal thinning and irregular
astigmatism. The incidence of the disorder is approximately
1 in 2,000 individuals in the general population. [1]. Patients
may require penetrating or deep anterior lamellar keratoplasty
procedures when rigid gas permeable contacts fail to provide
functional  vision.  Collagen  cross-linking  with  topical
riboflavin  and  ultraviolet  A  irradiation  is  a  promising
treatment to stabilize the progressive stromal ectasia [2]. The
histopathology  of  KC  includes  breaks  in  the  epithelial
basement  membrane  and  Bowman’s  membrane,  marked
central stromal thinning, anterior stromal scarring, iron in the
basal epithelium (Fleischer ring), and breaks in Descemet’s
membrane  (hydrops).  Keratocytes  are  responsible  for  the
formation and maintenance of Bowman’s membrane and the
stromal extracellular matrix.
The molecular pathogenesis of KC is poorly understood.
Decreased  corneal  levels  of  protease  inhibitors  (such  as
alpha-1 proteinase inhibitor and alpha-2 macroglobulin) and
increased levels of degradative enzymes may play a role in
the  stromal  thinning  [3-9].  Oxidative  stress  may  also
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contribute to the pathogenesis of KC [10-19]. Keratoconus
keratocytes (fibroblasts) have been shown to have increased
production  of  reactive  oxygen/nitrogen  species,  increased
catalase  activity,  and  higher  levels  of  H2O2  compared  to
controls [16].
A genetic basis of the disease is supported by evidence
of  Mendelian  inheritance  in  select  families  and  by  the
association of KC with chromosomal abnormalities such as
trisomy 21 [1]. Multiple gene loci probably contribute to the
pathogenesis  of  KC  based  on  preliminary  genome-wide
linkage  analysis  using  sibling  pair  families  [20].  Gene
expression  studies  performed  on  KC  keratoplasty  corneal
buttons  provide  a  unique  opportunity  to  delineate  the
molecular basis of the disorder. Lambiase et al. [21] reported
the absence of nerve growth factor receptor (TrkA) mRNA in
keratoconus  and  post-laser-assisted  in  situ  keratomileusis
(LASIK) ectasia buttons. Rabinowitz et al. [22] reported an
absence  of  transcripts  for  aquaporin  5  using  expressed
sequence tag (EST) analysis of the cDNA library that was
constructed from pooled KC keratoplasty buttons.
The recent advent of microarray based genomic analysis
has facilitated a systematic discovery of molecular pathways
impaired in human disease. Using microarrays to analyze the
epithelium from KC patients, Nielsen et al. [23] found altered
expressions of Charcot-Leyden crystal protein, desmoglein 3,
epithelial membrane protein 3, S100 calcium binding protein
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706A2, and secretory leukocyte peptidase inhibitor. Ha et al.
[24]  analyzed  cultured  KC  corneal  fibroblasts  using  a
microarray containing 164 human apoptosis genes and found
several that could play a role in the mechanism resulting in
stromal thinning.
In  our  current  study,  we  combined  evidence  from
genome-wide expression profiling of KC corneal fibroblasts,
western blot analysis of KC corneal fibroblast cell lysates, and
immunohistochemistry  of  archived  KC  keratoplasty
specimens  to  identify  genes  that  may  play  a  role  in  the
pathogenesis of KC.
METHODS
Corneal tissue: The study was approved by the Institutional
Review  Board  at  the  University  of  Texas  Southwestern
Medical Center (Dallas, TX) and was performed to the tenets
of the Declaration of Helsinki for research involving human
subjects. In this study, 18 keratoconus corneas, 10 normal
corneas, and 10 corneas with Fuchs’ endothelial dystrophy
were used.
Five normal corneas and three KC corneas were used for
microarray analysis. The normal corneas were donor corneas
obtained  from  Florida  Lions  Eye  Bank  (Tampa,  FL)
transported in Optisol GS corneal storage medium (Bausch &
Lomb, Rochester, NY) at 4 °C within 24 h post-mortem. The
KC corneas were collected from cornea fellowship trained
ophthalmologists within 24 h of the patient surgeries. The
keratoplasty  specimens  were  transported  in  Optisol  GS
(Bausch & Lomb) at 4 °C. The clinical diagnosis of KC was
made  by  corneal  specialists  based  on  slit  lamp  findings
(stromal thinning/ectasia, Fleischer ring, Vogt’s striae, and
subepithelial/stromal scarring) and/or on Placido ring corneal
topography signs.
Archived  surgical  keratoplasty  and  ocular  pathology
specimens (15 KC corneas, 5 normal corneas of whole globes
enucleated  for  other  pathology,  and  10  Fuchs’  corneal
endothelial  dystrophy)  were  examined  by
immunohistochemistry. The histopathologic diagnosis of KC
had been made by an ocular pathologist based on the presence
of breaks in the epithelial basement membrane and Bowman’s
membrane, central stromal thinning, anterior stromal scarring,
iron  in  basal  epithelium,  and/or  breaks  in  Descemet’s
membrane.  The  histopathologic  diagnosis  of  Fuchs’
dystrophy had been made by an ocular pathologist based on
the  presence  of  guttata  and  thickening  of  Descemet’s
membrane with attenuation of the endothelium.
Cell culture: Keratocytes (having a fibroblast morphology)
from keratoconus keratoplasty specimens and eye bank donor
corneas were isolated and expanded from stromal tissue using
serum  containing  medium.  Keratoplasty  specimens  were
dissected  in  Hanks’  buffered  saline  solution  (Life
Technologies  Inc.,  Grand  Island,  NY)  to  remove  the
epithelium and Descemet’s membrane with the endothelium.
The stromal tissue was cut into 1 mm3 pieces and used as
stromal explants for culture (at 37 °C in 5% CO2 humidified
incubator)  using  Dulbecco’s  modified  Eagle’s  medium
containing 10% fetal bovine serum, 100 µg/ml penicillin, 100
µg/ml  streptomycin,  and  0.2  µg/ml  amphotericin  B  (Life
Technologies Inc.). Cells between passages 0 and 3 were used
in this study.
RNA  isolation:  Approximately  2×106  cultured  keratocytes
were  lysed  for  RNA  isolation  using  Trizol®  reagent
(Invitrogen,  Carlsbad,  CA)  as  per  the  manufacturer’s
instructions. The cells were lysed in the tissue culture flask
using 1 ml/cm2 Trizol®. The homogenate was then transferred
to RNase free polypropylene tubes and incubated at room
temperature for 5 min. Chloroform (0.5 ml to 1 ml of Trizol®
used) was added to the homogenate, and the tubes were shaken
vigorously and then incubated at room temperature for 5 min
to allow complete mixing. The samples were then centrifuged
at 12,000x g for 15 min at 4 °C. The aqueous phase (upper
layer) containing the RNA was transferred to a fresh tube to
which 0.5 ml of isopropanol/ml of Trizol® was added. The
samples were then centrifuged at 12,000x g for 10 min at 4 °C
to pellet the RNA. The RNA pellet was then washed with 70%
ethanol and dissolved in 50–100 μl of RNase free water and
frozen at −80 °C for future use.
Hybridization:  Targets  from  cultured  fibroblasts  were
hybridized  to  the  Affymetrix  U133  Plus  2.0  GeneChip
microarray  (Affymetrix  Inc.,  Santa  Clara,  CA).  Gene
expression profiles were generated from three KC fibroblast
cultures  and  five  eye  bank  donor  fibroblast  cultures.  The
Affymetrix Microarray Suite Software (Affymetrix Inc.) was
used to acquire and process the data including the evaluation
of the abundance of each transcript. Gene expression levels
Figure 1. Fold change and p value data from microarray experiments.
Encircled  points  represent  transcripts  for  ADH1B  (Probe  sets
209612_s_at and 209613_s_at). Dashed line marks that p=0.05 and
statistical significance.
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707were  compared  for  fold  change  with  the  t-test  used  for
statistical significance (Excel; Microsoft, Seattle, WA).
Western blot analysis: Corneal fibroblast cells were treated
with 300–600 μl lysis buffer (2.5 ml 1 M Tris buffer [pH=7.0],
1 g SDS, and 2.5 g sucrose in 50 ml distilled water) for 10
min. Genomic DNA was sheared by several passes (~10–20)
through a 22 gauge needle, and samples were stored at –20 °C
until needed. BCA protein assays (Pierce, Rockford, IL) of
lysates were performed to ensure near equal loading of lanes.
SDS-PAGE was performed at room temperature (RT) on 20
μg protein/lane using 4%–15% Tris-HCl Ready Gels (Bio-
Rad, Hercules, CA) for 1 h and for 10 min at 95 V in Tris/
glycine/SDS  running  buffer.  Protein  transfer  onto
nitrocellulose membranes was performed by electroblotting
overnight (4 °C) at 25 mA in Tris/glycine buffer containing
20%  methanol.  Transfer  was  confirmed  by  Ponceau  Red
(Sigma-Aldrich  Corp.  St.  Louis,  MO)  staining  of  the
membranes. After de-staining in distilled water, membranes
were  blocked  for  30  min  (RT)  in  blocking  buffer  (5%
powdered milk and 1% BSA in PBS) and blocking continued
at 4 °C overnight followed by 30 min at room temperature the
next  morning.  The  solution  was  then  discarded.  The
membranes  were  incubated  with  the  primary  antibody
(ADH1B mouse polyclonal antibody raised against full length
recombinant ADH1B [Abnova, Taipaei, Taiwan]) diluted in
PBS overnight at 4 °C. Membranes were then rinsed three
times, each time for 10 min in PBS and 0.1% Tween-20 and
incubated with the secondary antibody for 1 h (RT). After
rinsing three times, each time for 10 min in PBS and 0.1%
Tween-20,  membranes  were  developed  (ECL
chemiluminescence;  Amersham  Biosciences,  Piscataway,
NJ). Densitometric analysis of bands was performed using
ImageJ image processing analysis in Java. Glyceraldehyde 3
phosphate dehydrogenase (GAPDH) was used as a loading
control for normalization of experiments that were repeated
three times.
Immunohistochemistry:  Immunohistochemistry  was
performed  on  five  micron  sections  of  archived  surgical
pathology cornea specimens that had been fixed in formalin
and embedded in paraffin. A monoclonal mouse IgG against
purified  human  liver  alcohol  dehydrogenase  (Biogenesis/
Morphosys  Inc.,  Kingston,  NH)  was  used.  Sections  were
mounted on charged slides and deparaffinized and rehydrated
through alcohol washes. Antigen retrieval was performed by
microwaving slides for 7 min in citrate buffer. The sections
were  then  incubated  with  the  primary  antibody  at  4  °C
overnight at a concentration of 12.6 µg/ml (1:30 dilution) in
2% BSA/PBS. Mouse IgG (BD PharMingen, San Jose, CA)
at 12.6 µg/ml was used as a negative control. Slides were
developed  with  3,3′-diaminobenzidine  (DAB;  Vector
Laboratories, Burlingame, CA) for 2 min and counterstained
with 0.5% methyl green. The specimens were dehydrated and
TABLE 1. FOLD CHANGE OF ALCOHOL DEHYDROGENASE GENE FAMILY IN KERATOCONUS FIBROBLASTS.
Gene Enzyme class Probe Set Fold change p value
ADH1A I 207820_at −1.8 0.23
ADH1B I 209612_s_at −212.5 0.04
209613_s_at −200.9 0.03
209614_at −148.2 0.07
ADH1C I 206262_at −20.8 0.01




ADH5 III 208848_at −2.0 0.0006
208847_s_at −1.7 0.02
ADH6 V 214261_s_at −1.10 0.88
207544_s_at 1.7 0.39
ADH7 IV 210505_at 1.0 0.94
Statistically significant decreases in ADH1B, ADH1C, and  ADH5  expression were found.
TABLE 2. EXPRESSION OF ADH1B IN KERATOCONUS FIBROBLASTS.
Probe set ID Keratoconus (n=3) Eye Bank control (n=5) Fold change p value
209612_s_at 114.67±180.04 24366.3±13426.45 −212.5 0.04
209613_s_at 73.37±65.06 14736.06±7719.59 −200.9 0.03
209614_at   18.1±7.8 2682.44±1834.4 −148. 0.07
Raw expression values are mean±standard deviation. “n” indicates the number of different samples.
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708coverslipped  with  Permount  (Thermo  Fisher  Scientific,
Waltham, MA). Stromal keratocyte staining of five archived
keratoconus keratoplasty buttons were graded in a masked
fashion by two observers using a 0 to 3+ scale and were
compared to five archived normal corneas of whole globes
enucleated  for  posterior  segment  pathology.  In  a  separate
batch of immunohistochemistry experiments, the staining of
stromal keratocytes in 10 archived keratoconus keratoplasty
buttons were compared with the same in 10 archived Fuchs’
endothelial corneal dystrophy keratoplasty buttons.
RESULTS
Microarray  analysis:  Three  different  keratoconus
keratoplasty specimens and five donor corneas from the eye
bank, which acted as controls, were used for cell culture. The
keratoconus specimens were from patients with a mean age
of 25 years (age range: 18–29), and the mean age of the donor
corneas from the eye bank was 24 years (age range: 17–30).
Fold change and p value data from the microarray experiment
are presented graphically as a volcano plot in Figure 1. Of over
54,000 probe sets analyzed with the Affymetrix platform,
3,900 were differentially expressed in the two groups using a
p value of 0.05 for statistical significance. Marked decreases
in  alcohol  dehydrogenase  (class  I)  beta  polypeptide
(ADH1B), (class I) gamma polypeptide (ADH1C), and (class
Figure 2. Protein expression of 80 kDa dimer and 40 kDa monomer
subunits of alcohol dehydrogenase in cultured corneal fibroblasts.
C1-C5  are  normal  corneal  fibroblast  cell  lines,  and  K1–K3  are
keratoconus corneal fibroblast cell lines.
III) chi polypeptide (ADH5) were seen (Table 1). Microarray
data analysis revealed up to a 212 fold reduction in the mRNA
levels of alcohol dehydrogenase (class I) beta polypeptide
(ADH1B)  in  the  keratoconus  fibroblasts  (p=0.04).  Raw
expression levels of the ADH1B probe set are presented in
Table 2. The ADH1B and ADH5 raw probe set expression
levels in the controls were robust enough to qualify for the
“present”  transcript  abundance  call  by  the  Affymetrix
Microarray Suite Software.
Western blot analysis: Western blot analysis of the cell lysates
of  corneal  fibroblasts  using  ADH1B  mouse  polyclonal
antibody detected 40 kDa monomer subunits and 80 kDa
dimer  forms  of  the  enzyme  (Figure  2).  Mean  adjusted
densitometry of the alcohol dehydrogenase (ADH) bands was
0.14 in the KC group versus 0.44 in the normal fibroblasts
(p=0.03; Table 3).
Immunohistochemistry: Immunohistochemistry experiments
confirmed decreased protein levels of alcohol dehydrogenase
in the stromal keratocytes of keratoconus corneas compared
to normal corneas and Fuchs’ dystrophy corneas (Figure 3).
Immunohistochemistry  using  a  monoclonal  mouse  IgG
against purified human liver alcohol dehydrogenase revealed
a mean staining intensity of 0.1 in the stromal keratocytes in
the keratoconus group compared to 1.4 in the normal cornea
group  (p=0.001;  Table  4).  In  a  separate  series  of
immunohistochemistry  experiments,  there  was  a  mean
intensity of 0.6 in the stromal keratocytes of the keratoconus
group compared to 1.7 in the Fuchs’ group (p=.005; Table 4).
DISCUSSION
ADH1B  and  ADH1C  respectively  code  for  the  beta  and
gamma  polypeptide  of  the  class  I  human  alcohol
dehydrogenase  enzyme.  ADH5  encodes  for  the  chi
polypeptide of the class III human alcohol dehydrogenase.
Alcohol  dehydrogenase  (ADH)  is  a  dimeric  zinc
metalloenzyme  with  40  kDa  subunits  that  catalyzes  the
reversible oxidation of alcohols to aldehydes (Figure 4) [25].
Enzymes within one class form homodimers and heterodimers
with each other [25]. The ADH genes are expressed in a tissue
specific pattern in the body and are important in detoxification
pathways with the substrate ranging from methanol to long
chain alcohols and sterols (retinol) [25].
TABLE 3. NORMALIZED DENSITOMETRY OF ALCOHOL DEHYDROGENASE WESTERN BLOT BANDS.
Specimen Keratoconus fibroblasts Normal fibroblasts
Sample 1 0.22±0.03 0.6±0.03
Sample 2 0.09±0.01 0.59±0.03
Sample 3 0.11 ±0.2 0.49±0.01
Sample 4   0.22±0.03
Sample 5   0.32±0.01
Mean density*±SEM 0.14±0.04 0.44±0.07
The asterisk indicates that p=0.03. The western blots were repeated three times with each sample.
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709The monoclonal mouse IgG against purified human liver
alcohol dehydrogenase used in our immunohistochemistry
experiments  would  be  expected  to  stain  multiple  ADH
isoenzymes encoded by ADH1A, ADH1B, ADH1C, ADH4,
Figure  3.  Alcohol  dehydrogenase  immunoreactivity  in  a  normal
cornea,  Fuchs’  dystrophy  cornea,  and  keratoconus  cornea.
Diaminobenzidine  (DAB)  brown  staining  of  the  keratocytes  of
normal corneas and Fuchs’ dystrophy corneas indicates presence of
alcohol dehydrogenase in contrast to keratoconus keratocytes.
ADH5, and ADH6. The ADH1B mouse polyclonal antibody
used for the western blot experiments would be expected to
additionally detect the gene products of ADH1A and ADH1C
based on protein BLAST. The three class I ADHs are 94%
identical in protein sequence, and there is a 60% sequence
identity among different ADH classes [25]. The distribution,
potential substrates, and functions of the various isoenzymes
of alcohol dehydrogenase in the human cornea require further
study.
Using  a  proteomics  approach  to  identify  the  most
abundant water soluble proteins in serum cultured human
corneal fibroblasts, Karring et al. [26] reported the detection
of  alcohol  dehydrogenase.  This  proteomics  data  taken
together with our mRNA data, which show robust levels of
ADH1B and ADH5 transcripts in normal corneal fibroblasts,
indicate that alcohol dehydrogenase is indeed important for
normal corneal fibroblast physiology.
Julia et al. [27] reported significant presence of alcohol
dehydrogenase (ADH) and aldehyde dehydrogenase (ALDH)
in the rat cornea and suggested that these consecutive enzymes
in  the  alcohol  oxidation  pathway  may  play  a  role  in  the
detoxification of compounds produced by lipid peroxidation
(high exposure to ultraviolet [UV] light and oxygen). Downes
et al. [28] reported that treatment of adult male C57BL / 6J
inbred mice with ultraviolet radiation (302 nm, 282 mW/
cm2, for 1 h) resulted in a marked reduction of ADH and
ALDH  activity  to  15%–16%  of  control  animals  with
subsequent  corneal  clouding.  Our  finding  of  substantial
reduction of alcohol dehydrogenase in keratoconus adds to the
growing body of evidence that oxidative stress may contribute
to the pathogenesis of KC [10-19].
Mouse knockout and other genetic studies have shown
that ADH and ALDH play an important in vivo function in
retinoid metabolism [29-31]. Retinoids are important for the
regulation  of  normal  growth,  development,  and  cellular
maintenance.  Retinol  (vitamin  A)  is  a  prerequisite  for  a
normal  conjunctival  and  corneal  surface  with  deprivation
resulting  in  xerophthalmia  where  there  is  a  reduction  of
conjunctival  goblet  cells,  in  keratinization  of  the  ocular
surface, and in keratomalacia (stromal ulceration) [32]. In
1939,  Mutch  et  al.  [33]  described  keratoconus  produced
experimentally in the rat with vitamin A deprivation. Retinoic
acid  has  been  shown  to  inhibit  expression  of  collagenase
enzymes in cultured corneal fibroblasts from rabbits [34]. We
Figure 4. Alcohol dehydrogenase is a dimeric zinc metalloenzyme
that catalyzes the reversible oxidation of alcohols to aldehydes.
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710can  also  speculate  that  a  disturbance  in  ADH/ALDH
homeostasis may disrupt the reaction of collagen aldehydes
reacting  with  other  collagen  amino  acids  required  in  the
intrinsic cross-linking process in the self-assembly of collagen
fibrils [35].
Keratoconus  research  has  been  hampered  by  the
difficulty of obtaining satisfactory corneal tissue for study
from keratoconus patients and suitable control tissue. We
cultured  corneal  fibroblasts  from  patients  with  advanced
keratoconus  requiring  keratoplasty.  We  acknowledge  that
scarring and other effects of previous treatments such as rigid
gas permeable contact lens use may alter gene and protein
expression. Age-matched donor corneas from an eye bank
were used to generate our control cell lines for the microarray
and western blot experiments. To further validate our finding
of  decreased  alcohol  dehydrogenase  expression  in
keratoconus,  we  performed  immunohistochemistry
experiments  comparing  archived  keratoconus  keratoplasty
specimens to a small number of normal corneas from whole
globes  enucleated  for  posterior  segment  pathology.  In  a
second batch of immunohistochemistry experiments, we were
able to compare a larger number of archived keratoconus
keratoplasty  specimens  to  archived  Fuchs’  dystrophy
keratoplasty specimens that were readily available to us. The
pathology of Fuchs’ dystrophy arises in the endothelial cell
layer  resulting  in  stromal  edema  with  patients  requiring
keratoplasty  much  later  in  life  than  those  patients  with
keratoconus. However, alcohol dehydrogenase levels were
also  markedly  decreased  in  the  stromal  keratocytes  in
keratoconus compared to the unrelated corneal endothelial
disorder of Fuchs’ dystrophy.
Our mRNA data suggest that the corneal fibroblast cell
line  is  markedly  altered  in  keratoconus.  Although  other
proteomics studies have shown that alcohol dehydrogenase is
highly  expressed  by  normal  corneal  fibroblasts  [26],  this
current  study  has  shown  that  ADH1B  is  the  most
downregulated  gene  in  keratoconus  fibroblasts  at  the
transcript  level.  Decreased  levels  of  ADH  protein  in
keratoconus  fibroblasts  are  supported  by  our
immunohistochemistry  and  western  blot  data.  Given  the
importance of the enzyme in numerous metabolic pathways,
we suggest that the absence of alcohol dehydrogenase is a
robust  marker  and  potentially  a  mediator  of  keratoconus.
Further  studies  regarding  the  distribution  and  potential
substrates of the alcohol dehydrogenase enzyme family in
normal human cornea are required before we can understand
the physiologic significance of reduced levels of ADH in
keratoconus.
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